Genetic and nongenetic sources of variation in phospholipid transfer protein activity[S]

Phospholipid transfer protein (PLTP) belongs to the lipid transfer/lipopolysaccharide-binding protein gene family. Expression of PLTP has been implicated in the development of atherosclerosis. We evaluated the effects of PLTP region tagging single nucleotide polymorphisms (SNPs) on the prediction of both carotid artery disease (CAAD) and PLTP activity. CAAD effects were evaluated in 442 Caucasian male subjects with severe CAAD and 497 vascular disease-free controls. SNP prediction of PLTP transfer activity was evaluated in both a subsample of 87 subjects enriched for an allele of interest and in a confirmation sample of 210 Caucasian males and females. Hemoglobin A1c or insulin level predicted 11–14% of age- and sex-adjusted PLTP activity. PLTP SNPs that predicted ∼11–30% of adjusted PLTP activity variance were identified in the two cohorts. For rs6065904, the allele that was associated with CAAD was also associated with elevated PLTP activity in both cohorts. SNPs associated with PLTP activity also predicted variation in LDL-cholesterol and LDL-B level only in the replication cohort. These results demonstrate that PLTP activity is strongly influenced by PLTP region polymorphisms and metabolic factors.

[1]  V. Chopra,et al.  Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. , 2009, Atherosclerosis.

[2]  F. Grosveld,et al.  Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism. , 2009, Biochimica et biophysica acta.

[3]  F. Grosveld,et al.  Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. , 2009, Atherosclerosis.

[4]  José A Fernández,et al.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. , 2009, Biochimica et biophysica acta.

[5]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[6]  C. Eng,et al.  Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. , 2008, Metabolism: clinical and experimental.

[7]  Yongtao Guan,et al.  Practical Issues in Imputation-Based Association Mapping , 2008, PLoS genetics.

[8]  F. Grosveld,et al.  Acute Elevation of Plasma PLTP Activity Strongly Increases Pre-existing Atherosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[10]  L. Curtiss,et al.  Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency Published, JLR Papers in Press, October 10, 2007. , 2008, Journal of Lipid Research.

[11]  J. Iqbal,et al.  Phospholipid Transfer Protein–Deficient Mice Absorb Less Cholesterol , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Stephens,et al.  Imputation-Based Analysis of Association Studies: Candidate Regions and Quantitative Traits , 2007, PLoS genetics.

[13]  M. Jauhiainen,et al.  Macrophage Phospholipid Transfer Protein Contributes Significantly to Total Plasma Phospholipid Transfer Activity and Its Deficiency Leads to Diminished Atherosclerotic Lesion Development , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Smit,et al.  Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus , 2006, Diabetologia.

[15]  E. Wijsman,et al.  Low-Density Lipoprotein Particle Size Loci in Familial Combined Hyperlipidemia: Evidence for Multiple Loci From a Genome Scan , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  T. van Gent,et al.  Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins Published, JLR Papers in Press, March 1, 2004. DOI 10.1194/jlr.M300487-JLR200 , 2004, Journal of Lipid Research.

[17]  S. Blankenberg,et al.  High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Jauhiainen,et al.  Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.M200281-JLR200 , 2003, Journal of Lipid Research.

[19]  A. Chait,et al.  Cell‐Associated and Extracellular Phospholipid Transfer Protein in Human Coronary Atherosclerosis , 2003, Circulation.

[20]  D. Mangelsdorf,et al.  The Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic Lesions , 2003, Molecular and Cellular Biology.

[21]  M. Taskinen,et al.  Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes. , 2002, Diabetes.

[22]  P. Eacho,et al.  Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo * , 2002, The Journal of Biological Chemistry.

[23]  J. Brunzell,et al.  Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution DOI 10.1194/jlr.M100373-JLR200 , 2002, Journal of Lipid Research.

[24]  J. Albers,et al.  Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. , 2001, Diabetes.

[25]  D. Moore,et al.  The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression* , 2000, The Journal of Biological Chemistry.

[26]  G. Schellenberg,et al.  Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[27]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[28]  J. Hokanson,et al.  PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. , 2000, Journal of lipid research.

[29]  J. Albers,et al.  DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. , 1999, Biochemical and biophysical research communications.

[30]  A. Tall,et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.

[31]  R. Dullaart,et al.  Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. , 1998, Atherosclerosis.

[32]  P Ducimetière,et al.  Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. , 1997, American journal of human genetics.

[33]  W. Reitsma,et al.  Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. , 1997, Scandinavian journal of clinical and laboratory investigation.

[34]  S. Tishkoff,et al.  Global Patterns of Linkage Disequilibrium at the CD4 Locus and Modern Human Origins , 1996, Science.

[35]  J. Albers,et al.  Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. , 1995, Biochimica et biophysica acta.

[36]  W. Sluiter,et al.  Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism , 1994, European journal of clinical investigation.

[37]  T. Nishida,et al.  High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. , 1993, The Journal of biological chemistry.

[38]  M. Jauhiainen,et al.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion. , 1993, The Journal of biological chemistry.

[39]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[40]  A. Tall,et al.  Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. , 1985, Journal of lipid research.

[41]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[42]  J. Durbin,et al.  Testing for serial correlation in least squares regression. II. , 1950, Biometrika.

[43]  S. Blankenberg,et al.  patient-oriented and epidemiological research PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study , 2009 .

[44]  B. Foeger,et al.  Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. , 2008, Atherosclerosis.

[45]  B. G. Brown,et al.  Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. , 2006, Biochimica et biophysica acta.

[46]  J. Albers,et al.  Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. , 1988, Journal of lipid research.

[47]  J. Durbin,et al.  Testing for serial correlation in least squares regression. I. , 1950, Biometrika.